Drug
Gk530g
Gk530g: highest development phase Phase 3, developed by Galderma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Galderma
Trials
| Drug | Phase | Indication |
|---|---|---|
| GK530G NCT01910064 | Phase 3 | Acne Vulgaris |
Latest
No recent events.
Follow Gk530g on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.